What is NDC 23731-6051?

23731-6051 is the product NDC for Anticoagulant Citrate Dextrose A, Dextrose monohydrate .245 g/10mL + 2 more ingredients solution, listed with the FDA by Citra Labs LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Anticoagulant Citrate Dextrose A (Anhydrous Citric Acid, Dextrose Monohydrate, and Trisodium Citrate Dihydrate).

What is the active ingredient?

Dextrose monohydrate, Anhydrous citric acid, Trisodium citrate dihydrate.

Citra Labs LLC, NDC labeler code 23731. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Anticoagulant Citrate Dextrose A?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Anticoagulant Citrate Dextrose A NDC 23731-6051

NDC codes

FDA NDC Directory

Product NDC (as listed)23731-6051Labeler and product segments. Claims need a package NDC.

Product NDC at billing width23731-6051Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
23731-6051-1	2373160510123731605101	10 VIAL, SINGLE-USE in 1 CASE (23731-6051-1) / 30 mL in 1 VIAL, SINGLE-USE (23731-6051-3)Marketed from Aug 26, 2003
23731-6051-2	2373160510223731605102	25 VIAL, SINGLE-USE in 1 CASE (23731-6051-2) / 30 mL in 1 VIAL, SINGLE-USE (23731-6051-3)Marketed from Aug 26, 2003
23731-6051-3	2373160510323731605103	30 mL in 1 VIAL, SINGLE-USE (23731-6051-3)Marketed from Aug 26, 2003

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Anticoagulant Citrate Dextrose A
Generic name (nonproprietary): anhydrous citric acid, dextrose monohydrate, and trisodium citrate dihydrate
Active ingredients: Dextrose monohydrate — .245 g/10mLAnhydrous citric acid — .073 g/10mLTrisodium citrate dihydrate — .22 g/10mL
Dosage form: Solution
Route: Extracorporeal
Labeler: Citra Labs LLCNDC labeler code 23731
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication BN 020037
Marketing start: Aug 26, 2003
Listing expires: Dec 31, 2026
Other FDA classes: Acidifying Activity (Mechanism)Acidifying Activity (Mechanism)Calcium Chelating Activity (Mechanism)Calcium Chelating Activity (Mechanism)Decreased Coagulation Factor Activity (Physiologic effect)Decreased Coagulation Factor Activity (Physiologic effect)
Identifiers: Product ID 23731-6051_9a133b17-0377-431f-b839-3e090fdabd78SPL ID 9a133b17-0377-431f-b839-3e090fdabd78SPL set ID 5bcd261e-ebba-4ecb-af22-e5aaeb04499bUNII LX22YL083G, XF417D3PSL, B22547B95K
Pharmacologic class: Anti-coagulant; Calculi Dissolution Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N423731605101 followed by a unit qualifier and the quantity

Package 23731-6051-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 14, 2023.

Indications (excerpt from the label)

Indications and Usage Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. (ACD-A), is intended for use as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP). Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 23731-6051

What is NDC 23731-6051?: 23731-6051 is the product NDC for Anticoagulant Citrate Dextrose A, Dextrose monohydrate .245 g/10mL + 2 more ingredients solution, listed with the FDA by Citra Labs LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Anticoagulant Citrate Dextrose A (Anhydrous Citric Acid, Dextrose Monohydrate, and Trisodium Citrate Dihydrate).
What is the active ingredient?: Dextrose monohydrate, Anhydrous citric acid, Trisodium citrate dihydrate.
Who is the labeler?: Citra Labs LLC, NDC labeler code 23731. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Anticoagulant Citrate Dextrose A?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.